whitepaper

Poster: Advantages of recombinant antibody engineering

Posted: 13 December 2019 | | No comments yet

Antibodies play a critical role in diagnostics and therapeutics. In these, and other applications, performance and consistency are critical.

The capability to convert an existing hybridoma-derived antibody to a recombinant antibody, cloning of the antibody from B-cells and engineering the antibodies for specific applications offers many advantages. Among these are consistency, long-term supply, high yields, enhanced stability, and activity.

As the industry moves towards dependence on recombinant antibody technologies, R&D Systems has been on the leading edge of the effort to advance the field of antibody engineering,











To read this poster in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Bio-Techne

Related topics
,

Related organisations

Send this to a friend